In recent trading, shares of Insulet Corp (Symbol: PODD) have crossed above the average analyst 12-month target price of $320.60, changing hands for $321.41/share. When a stock reaches the target ...

In trading on Tuesday, shares of Insulet Corp (Symbol: PODD) crossed above their 200 day moving average of $251.01, changing hands as high as $252.63 per share. Insulet Corp shares are currently ...

Now that offices are reopening, remote work is becoming a status symbol again—but this time for the employees with the greatest bargaining power. As a perk being offered only to the few ...

Insulet Corporation PODD is likely to gain in the coming quarters ... Further, Insulet is making good headway in the developmental work to integrate Omnipod 5 with DexCom’s G7 and Abbott ...

Even as it pulled back along with the broader market, insulin pump maker Insulet Corporation (NASDAQ: PODD) was finding support along its 50-day line and remained in the buy range with a possible ...

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced plans to release its ...